Driven by GLP-1 shortages and FDA compounding restrictions, a multi-billion-dollar gray market for injectable peptides ...

A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin a century ago, say experts. Teplizumab is given through a drip every day ...

ATLANTA, May 19, 2026 /PRNewswire/ -- Glytec, the leading provider of a glycemic management technology platform for hospitals and health systems, today announced that a joint research team with ...

Glytec, the creator of GlytecOne, a single insulin management platform designed to support safe, consistent glycemic care across patients, acuity levels, and roles, has announced plans to move its ...

A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. Sens. Jeanne Shaheen (D-N.H.), Susan Collins (R-Maine ...

For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections.

Unexplained hyperglycemic episodes in patients with type 1 diabetes (T1D) who are using automated insulin delivery (AID) systems may be a sign of undetected occlusions, new data showed. In addition, ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Unomedical, a subsidiary of Convatec and a supplier of ...

BOSTON, Sept. 16, 2025 /PRNewswire/ -- Glytec, the leading provider of an AI-powered diabetes platform for hospitals and health systems, today announced that Healthcare Tech Outlook named Glytec its ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels. A fixed-dose regimen of insulin efsitora alfa ...